{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"0.400","floor":"0.300"},"ipodate":{"start":"2020-12-15 00:00:00","end":"2020-12-18 00:00:00"},"minimumcapital":"4040.31","subscribed":"386.00","marketcap":"8.22億","H_marketcap":"--","pe":"75.47","codesrate":"3.00","link":"https://staticpdf.iqdii.com/stockdata/notice/02135/2020/2020121500149_c.pdf","ipopricing":"0.400","resultdate":"2020-12-24 00:00:00","enddate":"2020-12-18 00:00:00","listeddate":"2020-12-28 00:00:00","issuenumber":"34250.00萬","issuenumberhK":"17125.00萬","issuenumberother":"17125.00萬","grayprice":"0.48","sponsors":"創升融資有限公司","raisemoney":"7040.00萬","use":"1、約28.0%，或19.7百萬港元，將用作翻新所有現有醫療美容機構并擴張杭州瑞麗、瑞麗天鴿及蕪湖瑞麗，以提升能力、更新品牌形象及擴大市場份額；\n2、約28.0%，或19.7百萬港元，將用作為上海市新建醫療美容機構的資本支出及初始營運成本提供資金；\n3、約15.0%，或10.6百萬港元，將用作中國浙江省醫療美容機構的潛在戰略收購；\n4、約11.0%，或7.8百萬港元，將用作購買醫療美容服務設備及醫療消耗品，以完善若干醫療美容診療，擴大醫療美容服務范圍；\n5、約8.0%，或5.6百萬港元將用于積極推廣我們的品牌；\n6、約10%，或7.0百萬港元，將用作一般營運資金及其他一般公司用途。","shares":10000,"leadagent":"創升證券有限公司,千里碩證券有限公司,交銀國際證券有限公司,安信國際證券(香港)有限公司,First Fidelity Capital (International) Limited,麒麟證券有限公司,京基證券集團有限公司,偉祿亞太證券有限公司,太陽國際證券有限公司","bookrunners":"創升證券有限公司,千里碩證券有限公司,交銀國際證券有限公司,安信國際證券(香港)有限公司,First Fidelity Capital (International) Limited","coordinator":"創升證券有限公司,千里碩證券有限公司","firstDayOpen":"0.48","IsEiio":0,"Interestdays":6,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"創升證券有限公司","code":"E02135","name":"瑞麗醫美","fullname":"瑞麗醫美國際控股有限公司"},"institutioninfo":{"principaloffice":"中國杭州下城區中山北路290號民航大廈3–5樓","registrars":"卓佳證券登記有限公司","registrarstel":"(852) 2980 1333","chairman":"傅海曙","secretary":"陳愛發","telephone":"","substantialshareholders":"Ruide BVI(53.98%),美天下(6.28%),上海東婳(5.46%),Huamei Medical(5.46%)","principalactivities":"公司為一間位于中國浙江省的領先醫療美容服務供應商。","website":"http://www.ruilizx.com"},"managerinfo":[{"managername":"傅海曙","post":"主席兼執行董事","rankno":1},{"managername":"余凱","post":"行政總裁兼執行董事","rankno":2},{"managername":"宋建良","post":"執行董事","rankno":3}],"investorinfo":[{"institutionname":"昊海生物科技控股有限公司","shareholding":"50,000,000.0","percentage":14.6,"ReleaseDate":"2021-12-28 00:00:00","relatedparty":"上海昊海生物科技股份有限公司","subsidiary":["昊海生物科技控股有限公司"],"InverstorType":"公司"},{"institutionname":"途益香港有限公司","shareholding":"25,000,000.0","percentage":7.3,"ReleaseDate":"2021-06-28 00:00:00","relatedparty":"途屹控股有限公司","subsidiary":["途益香港有限公司"],"InverstorType":"公司"}],"TotalShareholdingPercentage":21.9},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":8}